Highly anticipated COVID-19 antivirals now sit on shelves

Federal data suggests at-home COVID-19 antiviral pills aren’t turning out to be the highly demanded game changers health experts anticipated, the Center for Infectious Disease Research and Policy reported Feb. 11.